These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3290383)

  • 1. Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A.
    Bessen D; Fischetti VA
    J Exp Med; 1988 Jun; 167(6):1945-50. PubMed ID: 3290383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant IgA production for mucosal passive immunization, advancing beyond the hurdles.
    Virdi V; Juarez P; Boudolf V; Depicker A
    Cell Mol Life Sci; 2016 Feb; 73(3):535-45. PubMed ID: 26511868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model.
    Shaw HA; Remmington A; McKenzie G; Winkel C; Mawas F
    Vaccines (Basel); 2023 Nov; 11(11):. PubMed ID: 38006056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils.
    Ozberk V; Zaman M; Lepletier A; Eskandari S; Kaden J; Mills JL; Calcutt A; Dooley J; Huo Y; Langshaw EL; Ulett GC; Batzloff MR; Good MF; Pandey M
    Nat Commun; 2023 Sep; 14(1):5963. PubMed ID: 37749129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group A Streptococcus Infection of the Nasopharynx Requires Proinflammatory Signaling through the Interleukin-1 Receptor.
    LaRock DL; Russell R; Johnson AF; Wilde S; LaRock CN
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32719155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection.
    Herrera AL; Van Hove C; Hanson M; Dale JB; Tweten RK; Huber VC; Diel D; Chaussee MS
    PLoS One; 2020; 15(6):e0235139. PubMed ID: 32574205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptococcus pyogenes genes that promote pharyngitis in primates.
    Zhu L; Olsen RJ; Beres SB; Saavedra MO; Kubiak SL; Cantu CC; Jenkins L; Waller AS; Sun Z; Palzkill T; Porter AR; DeLeo FR; Musser JM
    JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32493846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host Pathways of Hemostasis that Regulate Group A Streptococcus pyogenes Pathogenicity.
    Ploplis VA; Castellino FJ
    Curr Drug Targets; 2020; 21(2):193-201. PubMed ID: 31556853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of cryptic epitopes in designing a group A streptococcal vaccine.
    Ozberk V; Pandey M; Good MF
    Hum Vaccin Immunother; 2018; 14(8):2034-2052. PubMed ID: 29873591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Quorum Sensing-Regulated Protein Binds Cell Wall Components and Enhances Lysozyme Resistance in Streptococcus pyogenes.
    Gogos A; Jimenez JC; Chang JC; Wilkening RV; Federle MJ
    J Bacteriol; 2018 Jun; 200(11):. PubMed ID: 29555699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel platform technology for modular mucosal vaccine that protects against streptococcus.
    Zaman M; Ozberk V; Langshaw EL; McPhun V; Powell JL; Phillips ZN; Ho MF; Calcutt A; Batzloff MR; Toth I; Hill GR; Pandey M; Good MF
    Sci Rep; 2016 Dec; 6():39274. PubMed ID: 27976706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying protective Streptococcus pyogenes vaccine antigens recognized by both B and T cells in human adults and children.
    Mortensen R; Nissen TN; Fredslund S; Rosenkrands I; Christensen JP; Andersen P; Dietrich J
    Sci Rep; 2016 Feb; 6():22030. PubMed ID: 26911649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.
    Steinbach JM
    Cell Mol Life Sci; 2015 Feb; 72(3):469-503. PubMed ID: 25323132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity: an infection-related risk?
    Cunningham MW
    Curr Opin Rheumatol; 2013 Jul; 25(4):477-9. PubMed ID: 23689638
    [No Abstract]   [Full Text] [Related]  

  • 15. StreptInCor: a candidate vaccine epitope against S. pyogenes infections induces protection in outbred mice.
    Postol E; Alencar R; Higa FT; Freschi de Barros S; Demarchi LM; Kalil J; Guilherme L
    PLoS One; 2013; 8(4):e60969. PubMed ID: 23593359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genes, autoimmunity and pathogenesis of rheumatic heart disease.
    Guilherme L; Köhler KF; Postol E; Kalil J
    Ann Pediatr Cardiol; 2011 Jan; 4(1):13-21. PubMed ID: 21677799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge issues in rheumatic fever.
    Chang C
    Clin Rev Allergy Immunol; 2012 Apr; 42(2):213-37. PubMed ID: 21597903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue tropisms in group A streptococcal infections.
    Bessen DE; Lizano S
    Future Microbiol; 2010 Apr; 5(4):623-38. PubMed ID: 20353302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease.
    Batzloff MR; Pandey M; Olive C; Good MF
    Immunol Res; 2006; 35(3):233-48. PubMed ID: 17172649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils.
    Park HS; Cleary PP
    Infect Immun; 2005 Dec; 73(12):7878-86. PubMed ID: 16299278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.